Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov;61(11):980-5.
doi: 10.1136/thx.2006.062836. Epub 2006 Jul 14.

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

Affiliations

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

J Gribbin et al. Thorax. 2006 Nov.

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) and sarcoidosis are common diagnoses in patients attending chest clinics, but little is known about the epidemiology of these diseases. We used data from a general practice database to provide information on the current incidence of IPF and sarcoidosis in the UK.

Methods: Data were extracted for all patients with a diagnosis of IPF or sarcoidosis between 1991 and 2003. The whole population of the database was used to calculate disease incidence stratified by age, sex, region, and time period. Poisson regression was used to compare the incidence between populations and Cox regression was used to compare survival between populations.

Results: 920 cases of IPF (mean age 71 years, 62% male) and 1019 cases of sarcoidosis (mean age 47 years, 47% male) were identified. The overall incidence rate per 100 000 person-years was 4.6 for IPF and 5.0 for sarcoidosis. The incidence of IPF increased progressively between 1991 and 2003 (p<0.00001), and was highest in Northern England and Scotland (p<0.0001). The survival of patients with IPF was stable over time. In contrast, the incidence of sarcoidosis was highest in London, West Midlands and Northern Ireland and remained stable over time.

Conclusions: The incidence of IPF has more than doubled between 1990 and 2003; this is not due to the ageing of the UK population or an increased ascertainment of milder cases. The incidence of sarcoidosis has not changed during this time period. Our findings suggest that more than 4000 new cases of IPF and 3000 new cases of sarcoidosis are currently diagnosed each year in the UK.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none.

Similar articles

Cited by

References

    1. National Heart and Lung Institute Respiratory disease. Report on problems, research approaches, needs. 73‐432. Washington, DC: DHEW, 1972
    1. Johnston I, Britton J, Kinnear W.et al Rising mortality from cryptogenic fibrosing alveolitis. BMJ 19903011017–1021. - PMC - PubMed
    1. Hubbard R, Johnston I, Coultas D B.et al Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 199651711–716. - PMC - PubMed
    1. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population based cohort study. Chest 1998113396–400. - PubMed
    1. Mapel D W, Hunt W C, Utton R.et al Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax 199853469–476. - PMC - PubMed

Publication types